These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 14637161)

  • 1. Novel heparan mimetics potently inhibit the scrapie prion protein and its endocytosis.
    Schonberger O; Horonchik L; Gabizon R; Papy-Garcia D; Barritault D; Taraboulos A
    Biochem Biophys Res Commun; 2003 Dec; 312(2):473-9. PubMed ID: 14637161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel generation of heparan sulfate mimetics for the treatment of prion diseases.
    Adjou KT; Simoneau S; Salès N; Lamoury F; Dormont D; Papy-Garcia D; Barritault D; Deslys JP; Lasmézas CI
    J Gen Virol; 2003 Sep; 84(Pt 9):2595-2603. PubMed ID: 12917481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparan sulfate is a cellular receptor for purified infectious prions.
    Horonchik L; Tzaban S; Ben-Zaken O; Yedidia Y; Rouvinski A; Papy-Garcia D; Barritault D; Vlodavsky I; Taraboulos A
    J Biol Chem; 2005 Apr; 280(17):17062-7. PubMed ID: 15668247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scrapie prion protein accumulation by scrapie-infected neuroblastoma cells abrogated by exposure to a prion protein antibody.
    Enari M; Flechsig E; Weissmann C
    Proc Natl Acad Sci U S A; 2001 Jul; 98(16):9295-9. PubMed ID: 11470893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemical chaperones interfere with the formation of scrapie prion protein.
    Tatzelt J; Prusiner SB; Welch WJ
    EMBO J; 1996 Dec; 15(23):6363-73. PubMed ID: 8978663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycosylation-related gene expression in prion diseases: PrPSc accumulation in scrapie infected GT1 cells depends on beta-1,4-linked GalNAc-4-SO4 hyposulfation.
    Barret A; Forestier L; Deslys JP; Julien R; Gallet PF
    J Biol Chem; 2005 Mar; 280(11):10516-23. PubMed ID: 15632154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-activity studies of heparan mimetic polyanions for anti-prion therapies.
    Ouidja MO; Petit E; Kerros ME; Ikeda Y; Morin C; Carpentier G; Barritault D; Brugère-Picoux J; Deslys JP; Adjou K; Papy-Garcia D
    Biochem Biophys Res Commun; 2007 Nov; 363(1):95-100. PubMed ID: 17826736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-PrP antibodies block PrPSc replication in prion-infected cell cultures by accelerating PrPC degradation.
    Perrier V; Solassol J; Crozet C; Frobert Y; Mourton-Gilles C; Grassi J; Lehmann S
    J Neurochem; 2004 Apr; 89(2):454-63. PubMed ID: 15056288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sphingolipid depletion increases formation of the scrapie prion protein in neuroblastoma cells infected with prions.
    Naslavsky N; Shmeeda H; Friedlander G; Yanai A; Futerman AH; Barenholz Y; Taraboulos A
    J Biol Chem; 1999 Jul; 274(30):20763-71. PubMed ID: 10409615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The charge structure of helix 1 in the prion protein regulates conversion to pathogenic PrPSc.
    Norstrom EM; Mastrianni JA
    J Virol; 2006 Sep; 80(17):8521-9. PubMed ID: 16912302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparan Sulfate and Heparin Promote Faithful Prion Replication in Vitro by Binding to Normal and Abnormal Prion Proteins in Protein Misfolding Cyclic Amplification.
    Imamura M; Tabeta N; Kato N; Matsuura Y; Iwamaru Y; Yokoyama T; Murayama Y
    J Biol Chem; 2016 Dec; 291(51):26478-26486. PubMed ID: 27821590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dextran sulphate inhibits an association of prions with plasma membrane at the early phase of infection.
    Fuse T; Nakagaki T; Homma T; Tange H; Yamaguchi N; Atarashi R; Ishibashi D; Nishida N
    Neurosci Res; 2021 Oct; 171():34-40. PubMed ID: 33476681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of poly-L-arginine in inhibiting scrapie prion protein of cultured cells.
    Waqas M; Lee HM; Kim J; Telling G; Kim JK; Kim DH; Ryou C
    Mol Cell Biochem; 2017 Apr; 428(1-2):57-66. PubMed ID: 28063003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The tyrosine kinase inhibitor STI571 induces cellular clearance of PrPSc in prion-infected cells.
    Ertmer A; Gilch S; Yun SW; Flechsig E; Klebl B; Stein-Gerlach M; Klein MA; Schätzl HM
    J Biol Chem; 2004 Oct; 279(40):41918-27. PubMed ID: 15247213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Charged bipolar suramin derivatives induce aggregation of the prion protein at the cell surface and inhibit PrPSc replication.
    Nunziante M; Kehler C; Maas E; Kassack MU; Groschup M; Schätzl HM
    J Cell Sci; 2005 Nov; 118(Pt 21):4959-73. PubMed ID: 16219680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthetic scrapie infectivity: interaction between recombinant PrP and scrapie brain-derived RNA.
    Simoneau S; Thomzig A; Ruchoux MM; Vignier N; Daus ML; Poleggi A; Lebon P; Freire S; Durand V; Graziano S; Galeno R; Cardone F; Comoy E; Pocchiari M; Beekes M; Deslys JP; Fournier JG
    Virulence; 2015; 6(2):132-44. PubMed ID: 25585171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mimicking dominant negative inhibition of prion replication through structure-based drug design.
    Perrier V; Wallace AC; Kaneko K; Safar J; Prusiner SB; Cohen FE
    Proc Natl Acad Sci U S A; 2000 May; 97(11):6073-8. PubMed ID: 10823951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of Glycosaminoglycans Affects PrPSc Metabolism but Does Not Block PrPSc Uptake.
    Wolf H; Graßmann A; Bester R; Hossinger A; Möhl C; Paulsen L; Groschup MH; Schätzl H; Vorberg I
    J Virol; 2015 Oct; 89(19):9853-64. PubMed ID: 26202247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of guanidine on proteinase K resistance in vitro and infectivity of scrapie prion protein PrP(Sc).
    Gao JM; Zhou XB; Xiao XL; Zhang J; Chen L; Gao C; Zhang BY; Dong XP
    Acta Virol; 2006; 50(1):25-32. PubMed ID: 16599182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of prion propagation by dehydrocholesterol reductase inhibitors in cultured cells and a therapeutic trial in mice.
    Hagiwara K; Nakamura Y; Nishijima M; Yamakawa Y
    Biol Pharm Bull; 2007 Apr; 30(4):835-8. PubMed ID: 17409533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.